Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
20%
Ph early_phase_1
2
40%
Ph phase_4
1
20%
Ph phase_3
1
20%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)

Trials by Status

completed360%
not_yet_recruiting120%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingearly_phase_1

Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery

NCT07362992
completedphase_4

EFFECTS OF TRANEXAMIC ACID IN TUMESCENT SOLUTION FOR LIPOSUCTION PROCEDURES

NCT06648265
completedearly_phase_1

Combined IV and Topical TXA in Major Spine Surgery

NCT04797156
unknownphase_3

Use of Transexamic Acid in Hip Replacement

NCT02587845
completedphase_2

Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty

NCT02323373

Clinical Trials (5)

Showing 5 of 5 trials
NCT07362992Early Phase 1

Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery

Not Yet Recruiting
NCT06648265Phase 4

EFFECTS OF TRANEXAMIC ACID IN TUMESCENT SOLUTION FOR LIPOSUCTION PROCEDURES

Completed
NCT04797156Early Phase 1

Combined IV and Topical TXA in Major Spine Surgery

Completed
NCT02587845Phase 3

Use of Transexamic Acid in Hip Replacement

Unknown
NCT02323373Phase 2

Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5